Drug safety in paediatric anaesthesia

J Kaufmann1,2, A R Wolf3, K Becke4

  • 1Department for Paediatric Anaesthesia, Children's Hospital Cologne, Cologne, Germany.

Insights

Preventing drug errors in pediatric anesthesia is crucial due to unique patient factors. This review identifies cost-effective strategies to improve medication safety and quality of care for children undergoing anesthesia.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Patient Safety

Background:

  • Life-threatening medication errors are more frequent in pediatric patients compared to adults.
  • Variations in pediatric age and weight, coupled with infrequent exposure for many anesthesiologists, increase risk.
  • Drug administration in pediatric anesthesia, often a single-operator task, poses higher risks than in other medical fields.

Purpose of the Study:

  • To conduct a narrative systematic review of current evidence and recommendations for preventive strategies.
  • To identify feasible measures that enhance the safety and quality of drug administration in pediatric anesthesia.
  • To collate and grade the evidence supporting interventions and assess their practical applicability.

Main Methods:

  • Systematic review of existing literature and recommendations.
  • Evidence collation and grading for preventive interventions.
  • Feasibility assessment of identified strategies.

Main Results:

  • Most effective preventive measures for pediatric anesthesia drug errors are low-cost and require limited labor.
  • Identified strategies aim to improve medication safety and quality of care.
  • The review grades evidence and assesses the feasibility of interventions.

Conclusions:

  • Low-cost, low-labor interventions are highly effective in enhancing pediatric anesthesia medication safety.
  • Implementing these feasible strategies can significantly improve patient safety and care quality.
  • Standardized, evidence-based practices are essential for reducing drug errors in pediatric anesthesia.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
821
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293